Elamipretide Failed to Meet Promise of Earlier Trial Results for Primary Mitochondrial Myopathy, Data Show
Treatment candidate elamipretide did not meet expectations stemming from promising early trial results in patients with primary mitochondrial myopathy (PMM), data from a Phase 3 trial show. Elamipretide is an experimental medicine designed to treat both inherited primary mitochondrial diseases and mitochondrial dysfunction in age-related diseases. It…